XFOR icon

X4 Pharmaceuticals
XFOR

Overview Fund Activity

93 hedge funds and large institutions have $81.5M invested in X4 Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
+2
Holders Change %
+2.2%
% of All Funds
1.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
28
Reduced
22
Closed
14
Calls
$195K
Puts
$426K
Net Calls
-$231K
Net Calls Change
-$60K

Top Buyers

1
KCM
1
Kingdon Capital Management
New York
$2.91M
2
SCM
2
Sio Capital Management
New York
$3.01M
3
BCLSI
3
Bain Capital Life Sciences Investors
Massachusetts
$14.2M
4
Morgan Stanley
4
Morgan Stanley
New York
$673K
5
GCP
5
GSA Capital Partners
United Kingdom
$793K

Top Sellers

1
PCH
1
Polar Capital Holdings
United Kingdom
$0
2
TLP
2
Tri Locum Partners
New York
$0
3
SCM
3
Stonepine Capital Management
Oregon
$0
4
Millennium Management
4
Millennium Management
New York
$1.4M
5
MIM
5
Monashee Investment Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TSS
101
Two Sigma Securities
New York
– -$35.2K -1,078 Closed
Wolverine Trading
102
Wolverine Trading
Illinois
– -$16.1K -492 Closed
Marshall Wace
103
Marshall Wace
United Kingdom
– -$14.1K -430 Closed
TCWM
104
Total Clarity Wealth Management
Illinois
– -$12.6K -384 Closed
1IA
105
1620 Investment Advisors
Massachusetts
– -$10.9K -333 Closed
MLICM
106
Metropolitan Life Insurance Company (MetLife)
New York
– -$7.39K -226 Closed
1 2 3 4
5